GlassScriptPhysician profile
Dawn M Holsted
NPI 1538214531
$3,129.36
in general payments reported to CMS, 2019-2025
16 companies · $692 in 2025
The $692 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $761 · 2020: $281 · 2021: $353 · 2022: $381 · 2023: $497 · 2024: $164 · 2025: $692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,352.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $576.24 | 2019-2021 | |
| Alcon Vision LLC | $438.53 | 2019-2025 | Argos, Clareon, Clareon Panoptix Pro |
| Bausch & Lomb Americas INC. | $331.04 | 2022-2025 | Miebo, Xiidra, Envista Mx60 Iol |
| Johnson & Johnson Surgical Vision, INC. | $319.27 | 2023-2025 | Catalys System, Tecnis Simplicity, Tecnis Iol |
| Allergan, INC. | $245.94 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $237.87 | 2019-2023 | Cequa |
| Staar Surgical Company | $170.49 | 2019 | |
| Harrow Eye, LLC | $156.49 | 2025 | Vevye |
| Glaukos Corporation | $144.41 | 2023 | Istent Infinite Trabecular Micro-Bypass System Model Is3, Istent Trabecular Micro-Bypass Stent System, Istent Inject Trabecular Micro-Bypass System |
| The Cameron-Ehlen Group, INC. | $142.72 | 2021 | |
| Shire North American Group INC | $118.84 | 2019 | |
| Carl Zeiss Meditec, INC. | $111.27 | 2020 | |
| Abbvie INC. | $46.18 | 2022-2023 | |
| Rxsight INC | $45.62 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.29 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $22.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Holsted listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.